NURS 520 Exam 1 Questions With
Correct Answers
Right |Patient
Confirm |patient's |identity |using |multiple |identifiers.
Right |Time
Verify |medication |frequency |and |last |dose |timing.
Right |Dose
Ensure |dosage |is |suitable |for |patient's |age |and |size.
Right |Route
Confirm |prescribed |route |is |appropriate |for |patient.
Right |Medication/Drug
Triple |check |medication |orders |against |label |before |administration.
Assessment
Data |collection |from |various |sources |to |organize |patient |information.
Human |Needs |Statement
Professional |nurses' |developed |statements |about |patient |needs.
Planning: |Outcome |Identification
Prioritize |needs |and |set |achievable |outcomes.
Implementation
Execution |of |nursing |actions |based |on |care |plan.
Evaluation
Systematic |monitoring |of |care |plan |effectiveness.
Subjective |Data
Patient's |spoken |information |like |complaints |or |needs.
,Objective |Data
Information |from |senses |and |medical |records.
Medication |Error |Resulting |in |Death
Serious |mistake |with |fatal |consequences |in |drug |administration
Patient |Identifiers
Two |unique |patient |details |used |to |confirm |identity |before |medication |
administration
Nine |Rights |of |Medication |Administration
Core |principles |ensuring |safe |drug |administration |practices
TACIT |Mnemonic
Tool |to |assess |therapeutic |effects, |allergies, |contraindications, |interactions, |
and |toxicity |of |drugs
Near |Miss
Situation |closely |resembling |an |adverse |event |but |with |no |harm |to |the |patient
Leading |Zeros |in |Medication |Orders
Omission |can |lead |to |overdose |risk, |always |use |'0.' |before |decimal |values
Calcium |Supplements
Essential |for |bone |health, |coagulation, |and |nervous |system |function
Vitamin |D |Deficiency |Conditions
Rickets, |osteomalacia, |and |tetany |caused |by |inadequate |Vitamin |D |levels
Thiamine |Deficiency |Symptoms
Beriberi |and |Wernicke's |encephalopathy |due |to |lack |of |Vitamin |B1
Vitamin |C |Functions
Essential |for |collagen |synthesis, |tissue |repair, |iron |absorption, |and |immune |
response
Acute |Pain
Sudden, |short-term |pain |resolving |with |treatment |within |6 |weeks
Chronic |Pain
, Persistent, |difficult-to-treat |pain |lasting |for |extended |periods
Somatic |Pain
Pain |originating |from |skin, |muscles, |or |connective |tissues |(ligaments/joints)
Neuropathic |Pain
Pain |resulting |from |nerve |damage |or |dysfunction
OTC |and |Dietary |Supplements |in |Pregnancy
Caution |advised |due |to |lack |of |FDA |regulation |and |potential |interactions
Gingko |Biloba |Interactions
May |increase |bleeding |risk |with |anticoagulants |and |antiplatelets
Opioid |Adverse |Effects
Includes |CNS |and |respiratory |depression, |hypotension, |sedation, |nausea, |
gastrointestinal, |genioutrinary, |integumentary, |respiratory
Opioid |Addiction
Compulsive |opioid |use |for |effects |beyond |pain |relief
Opioid |Tolerance
Condition |needing |larger |opioid |doses |for |same |effect
Opioid |Abstinence |Syndrome
Withdrawal |symptoms |from |opioid |dependence
Nalbuphine
Partial |agonist |opioid |with |lower |addiction |risk
Malignant |Hyperthermia
Fatal |metabolic |reaction |with |high |body |temp |and |rigidity
General |Anesthesia |Effects
Impaired |systems |like |respiratory, |cardiovascular, |and |CNS
Caffeine |Caution
Patients |with |peptic |ulcers, |cardiac |dysrhythmias, |or |recent |heart |attack
Methylphenidate |Assessment
Correct Answers
Right |Patient
Confirm |patient's |identity |using |multiple |identifiers.
Right |Time
Verify |medication |frequency |and |last |dose |timing.
Right |Dose
Ensure |dosage |is |suitable |for |patient's |age |and |size.
Right |Route
Confirm |prescribed |route |is |appropriate |for |patient.
Right |Medication/Drug
Triple |check |medication |orders |against |label |before |administration.
Assessment
Data |collection |from |various |sources |to |organize |patient |information.
Human |Needs |Statement
Professional |nurses' |developed |statements |about |patient |needs.
Planning: |Outcome |Identification
Prioritize |needs |and |set |achievable |outcomes.
Implementation
Execution |of |nursing |actions |based |on |care |plan.
Evaluation
Systematic |monitoring |of |care |plan |effectiveness.
Subjective |Data
Patient's |spoken |information |like |complaints |or |needs.
,Objective |Data
Information |from |senses |and |medical |records.
Medication |Error |Resulting |in |Death
Serious |mistake |with |fatal |consequences |in |drug |administration
Patient |Identifiers
Two |unique |patient |details |used |to |confirm |identity |before |medication |
administration
Nine |Rights |of |Medication |Administration
Core |principles |ensuring |safe |drug |administration |practices
TACIT |Mnemonic
Tool |to |assess |therapeutic |effects, |allergies, |contraindications, |interactions, |
and |toxicity |of |drugs
Near |Miss
Situation |closely |resembling |an |adverse |event |but |with |no |harm |to |the |patient
Leading |Zeros |in |Medication |Orders
Omission |can |lead |to |overdose |risk, |always |use |'0.' |before |decimal |values
Calcium |Supplements
Essential |for |bone |health, |coagulation, |and |nervous |system |function
Vitamin |D |Deficiency |Conditions
Rickets, |osteomalacia, |and |tetany |caused |by |inadequate |Vitamin |D |levels
Thiamine |Deficiency |Symptoms
Beriberi |and |Wernicke's |encephalopathy |due |to |lack |of |Vitamin |B1
Vitamin |C |Functions
Essential |for |collagen |synthesis, |tissue |repair, |iron |absorption, |and |immune |
response
Acute |Pain
Sudden, |short-term |pain |resolving |with |treatment |within |6 |weeks
Chronic |Pain
, Persistent, |difficult-to-treat |pain |lasting |for |extended |periods
Somatic |Pain
Pain |originating |from |skin, |muscles, |or |connective |tissues |(ligaments/joints)
Neuropathic |Pain
Pain |resulting |from |nerve |damage |or |dysfunction
OTC |and |Dietary |Supplements |in |Pregnancy
Caution |advised |due |to |lack |of |FDA |regulation |and |potential |interactions
Gingko |Biloba |Interactions
May |increase |bleeding |risk |with |anticoagulants |and |antiplatelets
Opioid |Adverse |Effects
Includes |CNS |and |respiratory |depression, |hypotension, |sedation, |nausea, |
gastrointestinal, |genioutrinary, |integumentary, |respiratory
Opioid |Addiction
Compulsive |opioid |use |for |effects |beyond |pain |relief
Opioid |Tolerance
Condition |needing |larger |opioid |doses |for |same |effect
Opioid |Abstinence |Syndrome
Withdrawal |symptoms |from |opioid |dependence
Nalbuphine
Partial |agonist |opioid |with |lower |addiction |risk
Malignant |Hyperthermia
Fatal |metabolic |reaction |with |high |body |temp |and |rigidity
General |Anesthesia |Effects
Impaired |systems |like |respiratory, |cardiovascular, |and |CNS
Caffeine |Caution
Patients |with |peptic |ulcers, |cardiac |dysrhythmias, |or |recent |heart |attack
Methylphenidate |Assessment
